POWL gains from strength across its end markets, diversification efforts and pro-shareholder policies. High operating expenses remain a concern.

Cervecerias Unidas (CCU) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

The heavy selling pressure might have exhausted for Banco Macro (BMA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your Krispy Kreme, Inc. (NASDAQ:DNUT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/krispy-kreme-inc-lawsuit-submission-form?prid=152436&wire=1&utm_campaign=9 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=152437&wire=1&utm_campaign=30 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / June 10, 2025 / If you suffered a loss on your Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/iovance-biotherapeutics-inc-lawsuit-submission-form?prid=152439&wire=1&utm_campaign=6 or contact Joseph E. Levi, Esq.

Redburn Atlantic earlier downgraded the shares of blue-chip fast food giant McDonald's Corp (NYSE:MCD) to "sell" form "buy," and cut its price target to $260 from $319.

NEW YORK, June 10, 2025 /PRNewswire/ -- Tiger Capital Group's lending platform, Tiger Finance, has provided $35 million in financing to The Beachbody Company, Inc. (NYSE:BODI), a leading fitness and nutrition company.

ANET's Arista 2.0 strategy gains momentum with AI, SaaS and new markets driving its next wave of growth.

SEZL is outpacing BNPL rivals with surging revenues, leaner operations and rising analyst confidence in 2025.

LAKE posts Q1 loss despite 28.7% sales growth, hit by rising costs and shrinking gross margins.

SIVR hits a 52-week high as silver surges past $36 amid supply deficits, dollar weakness and geopolitical uncertainty.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

PDUFA date of June 13th 2025 by which FDA will decide upon whether or not UGN-102 should be approved for patients with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer. The 7 major bladder cancer markets are expected to reach $5.4 billion by 2034. Company is developing anti-CTLA4 antibody UGN-301 in a phase 1 study either alone as a monotherapy or in combination to target patients with recurrent high-grade non-muscle invasive bladder cancer.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?